Back to Stories & News

DENVER/April 11, 2022 - Morris Animal Foundation announces a new funding opportunity for study proposals focusing on hepatitis in Doberman pinschers, specifically research projects that attempt to understand the cause(s) and specific pathologic mechanisms of Doberman hepatitis.

Particular interest will be given to proposals focused on early detection and phenotype-based and/or genomic estimated breeding value approaches.

“Doberman pinschers are at a higher risk of developing this condition compared with other breeds, and studies funded through this RFP will help us better understand why that is and what we can do about it,” said Dr. Janet Patterson-Kane, Morris Animal Foundation Chief Scientific Officer. “Something we’re particularly interested in is proposals from multidisciplinary teams of scientists and clinical researchers to provide perspective on bench-to-bedside translation.”

The maximum project duration for this request for proposals (RFP) is 36 months, with a maximum budget of $200,000 USD. Indirect costs are not permitted for this RFP. The Foundation will not accept studies targeting other breeds or projects proposing use of laboratory animals. Applications must be received by July 1, 2022, 4:59 p.m. ET.

Applications will be reviewed and rated, based on impact and scientific rigor, by a scientific advisory board, made up of subject matter experts. Interested researchers can learn more and apply for grant funding at Morris Animal Foundation. 

Funding for this RFP is provided by the Doberman Club of America.

About Morris Animal Foundation

Headquartered in Denver, and founded in 1948, it is one of the largest nonprofit animal health research organizations in the world, funding more than $136 million in critical studies across a broad range of species. Learn more at morrisanimalfoundation.org.

Media contact: Dane Madrid